List view / Grid view

Seahee Kim (Samsung Biologics)



Technologies and tactics for accelerating end-to-end biologic drug development

29 November 2021 | By

Creating new biologic drugs from early research is a complex process, but certain development methodologies and practices are proving to reach clinical and commercial goals faster. In this article, Seahee Kim from Samsung Biologics provides insight into how contract development and manufacturing organisations (CDMOs) are applying new and effective methodologies…